Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis
- PMID: 16969369
- DOI: 10.1038/labinvest.3700476
Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis
Abstract
Endothelial cells and pericytes play critical role in angiogenesis, which is controlled, in part, by the angiopoietin (Ang)/Tie-2 system and vascular endothelial growth factor (VEGF). Here, we investigated Ang, Tie-2, and VEGF expression within endothelial cells and pericyte interdigitations (EPI), which consist of cytoplasmic projections of pericytes and corresponding endothelial indentations. After subcutaneous implantation of a thermoreversible gelation polymer disc in rats, the capillary density was low on day 5, increased to a peak on day 7, and then decreased on days 10-20. A small number of EPI were observed on day 5, then increased sharply to a peak on day 10, but had decreased on day 20. Light and electron microscopy immunohistochemical and RNA in situ hybridization analyses revealed that Tie-2 localized at endothelial cells, and Ang-2 localized at endothelial cells and pericytes, while Ang-1 and VEGF localized at pericytes, and Ang-1 was most intensely observed at EPI of pericytes. Conventional quantitative RT-PCR and Western blot analyses revealed that the level of Ang-1 was low on days 5-7, then increased on days 10-20, while the level of VEGF was high on days 5-10, but had decreased on day 20. The level of Ang-2 remained high and Tie-2 remained at the level of the control on days 5-20. The present study showed that the angiogenic phase might be initiated by increases in Ang-2 and VEGF, while the microvessel maturation phase might be initiated by a relative increase in Ang-1 and a decrease in VEGF. Moreover, EPI might serve as a pathway for the Ang-1/Tie-2 system, with VEGF promoting pericyte recruitment for microvascular integrity.
Similar articles
-
Peritoneal morphologic changes in a peritoneal dialysis rat model correlate with angiopoietin/Tie-2.Pediatr Nephrol. 2009 Jan;24(1):163-70. doi: 10.1007/s00467-008-0944-5. Epub 2008 Aug 28. Pediatr Nephrol. 2009. PMID: 18751736
-
Connection of pericyte-angiopoietin-Tie-2 system in diabetic retinopathy: friend or foe?Future Med Chem. 2012 Nov;4(17):2163-76. doi: 10.4155/fmc.12.170. Future Med Chem. 2012. PMID: 23190105
-
Expression of angiopoietins, Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma.World J Gastroenterol. 2006 Jul 14;12(26):4241-5. doi: 10.3748/wjg.v12.i26.4241. World J Gastroenterol. 2006. PMID: 16830384 Free PMC article.
-
Ang-1 and VEGF: central regulators of angiogenesis.Mol Cell Biochem. 2025 Feb;480(2):621-637. doi: 10.1007/s11010-024-05010-3. Epub 2024 Apr 23. Mol Cell Biochem. 2025. PMID: 38652215 Review.
-
Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference.Cancer Lett. 2016 Oct 1;380(2):525-533. doi: 10.1016/j.canlet.2014.09.035. Epub 2014 Oct 12. Cancer Lett. 2016. PMID: 25312939 Free PMC article. Review.
Cited by
-
Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?Mol Oncol. 2011 Apr;5(2):137-49. doi: 10.1016/j.molonc.2011.01.003. Epub 2011 Feb 3. Mol Oncol. 2011. PMID: 21345752 Free PMC article. Review.
-
Mural cell associated VEGF is required for organotypic vessel formation.PLoS One. 2009 Jun 4;4(6):e5798. doi: 10.1371/journal.pone.0005798. PLoS One. 2009. PMID: 19495422 Free PMC article.
-
Pericyte antigens in angiomyolipoma and PEComa family tumors.Med Oncol. 2015 Aug;32(8):210. doi: 10.1007/s12032-015-0659-y. Epub 2015 Jun 30. Med Oncol. 2015. PMID: 26123600
-
Localization of angiopoietin-1 and Tie2 immunoreactivity in rodent ependyma and adjacent blood vessels suggests functional relationships.J Histochem Cytochem. 2010 Jan;58(1):53-60. doi: 10.1369/jhc.2009.954610. Epub 2009 Sep 28. J Histochem Cytochem. 2010. PMID: 19786610 Free PMC article.
-
Towards Cell free Therapy of Premature Ovarian Insufficiency: Human Bone Marrow Mesenchymal Stem Cells Secretome Enhances Angiogenesis in Human Ovarian Microvascular Endothelial Cells.HSOA J Stem Cells Res Dev Ther. 2019;5(2):019. doi: 10.24966/srdt-2060/100019. Epub 2019 Nov 6. HSOA J Stem Cells Res Dev Ther. 2019. PMID: 32494757 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous